zanubrutinib/sonrotoclax FDC (BG-71332)
/ BeOne Medicines
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 26, 2026
A Study to Investigate the Relative Bioavailability and Food Effect of a Fixed-Dose Combination Tablet Containing Zanubrutinib and Sonrotoclax (BG-71332) in Healthy Adults
(clinicaltrials.gov)
- P1 | N=24 | Completed | Sponsor: BeOne Medicines | Active, not recruiting ➔ Completed
Trial completion
February 06, 2026
A Study to Investigate the Relative Bioavailability and Food Effect of a Fixed-Dose Combination Tablet Containing Zanubrutinib and Sonrotoclax (BG-71332) in Healthy Adults
(clinicaltrials.gov)
- P1 | N=24 | Active, not recruiting | Sponsor: BeOne Medicines | Recruiting ➔ Active, not recruiting
Enrollment closed
1 to 2
Of
2
Go to page
1